Planned sales, announced before they happen
4 trading plans running, 40 Form 144 notices for $110.3M
Plans running now
4
Richard C. Puccio, Jr., Karen Golz, Ray Stata, Vincent Roche
What ADI's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Richard C. Puccio, Jr. Executive Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | May 21, 2026 | up to 14,292 | Feb 16, 2027 | 10-Q Aug 19, 2026 |
What the company wroteThe following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted or terminated by our directors or officers during the third quarter of fiscal 2026 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement). Name and Title Action Date of Adoption/ Termination Duration of Rule 10b5-1 Trading Arrangement Aggregate Number of Securities to Be Purchased or Sold Richard C. Puccio, Jr., Executive Vice President and Chief Financial Officer Adoption May 21, 2026 Until February 16, 2027, or such earlier date upon which all transactions are completed or expire without execution Sale of up to 14,292 shares | |||||
| Karen Golz Director |
Adopted 10b5-1 plan | Mar 12, 2026 | up to 3,000 | Mar 3, 2027 | 10-Q May 20, 2026 |
| Ray Stata Director |
Adopted 10b5-1 plan | Mar 6, 2026 | up to 34,000 | May 6, 2027 | 10-Q May 20, 2026 |
| Vincent Roche Chief Executive Officer and Chair of the Board of Directors |
Adopted 10b5-1 plan | Dec 3, 2025 | up to 120,000 | May 3, 2027 | 10-Q Feb 18, 2026 |
What the company wroteThe following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted or terminated by our directors or officers during the first quarter of fiscal 2026 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement). Name and Title Action Date of Adoption/ Termination Duration of Rule 10b5-1 Trading Arrangement Aggregate Number of Securities to Be Purchased or Sold Vincent Roche Chief Executive Officer and Chair of the Board of Directors Adoption December 3, 2025 Until May 3, 2027, or such earlier date upon which all transactions are completed or expire without execution Sale of up to 120,000 shares | |||||
| Vincent Roche Chief Executive Officer and Chair of the Board of Directors |
Ended 10b5-1 plan | May 23, 2025 | up to 90,000 | May 1, 2026 | 10-Q Aug 20, 2025 |
What the company wroteThe following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted or terminated by our directors or officers during the third quarter of fiscal 2025 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement). Name and Title Action Date of Adoption/ Termination Duration of Rule 10b5-1 Trading Arrangement Aggregate Number of Securities to Be Purchased or Sold Vincent Roche Chief Executive Officer and Chair of the Board of Directors Termination May 23, 2025 (1) Until May 1, 2026, or such earlier date upon which all transactions are completed or expire without execution Sale of up to 140,000 shares (2) Vincent Roche Chief Executive Officer and Chair of the Board of Directors Adoption May 23, 2025 (1) Until May 1, 2026, or such earlier date upon which all transactions are completed or expire without execution Sale of up to 90,000 shares (1) Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a Rule 10b5-1 trading arrangement originally adopted on March 13, 2025. (2) As of the date of termination, no shares of our common stock had been sold under the Rule 10b5-1 trading arrangement. | |||||
| Vincent Roche Chief Executive Officer and Chair of the Board of Directors |
Adopted 10b5-1 plan | Mar 13, 2025 | up to 140,000 | May 1, 2026 | 10-Q May 22, 2025 |
What the company wroteThe following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our directors or officers during the second quarter of fiscal 2025 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement). Name and Title Date of Adoption Duration of Rule 10b5-1 Trading Arrangement Aggregate Number of Securities to Be Purchased or Sold Vincent Roche Chief Executive Officer and Chair of the Board of Directors March 13, 2025 Until May 1, 2026, or such earlier date upon which all transactions are completed or expire without execution Sale of up to 140,000 shares | |||||
| Ray Stata Director |
Adopted 10b5-1 plan | Jan 9, 2025 | up to 75,000 | Mar 11, 2026 | 10-Q Feb 19, 2025 |
| Mercedes Johnson Director |
Adopted 10b5-1 plan | Dec 3, 2024 | up to 6,000 | Jun 2, 2025 | 10-Q Feb 19, 2025 |
| Richard C. Puccio, Jr. Executive Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Sep 17, 2024 | up to 5,000 | Apr 30, 2025 | 10-K Nov 26, 2024 |
What the company wroteThe following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our directors or officers during the fourth quarter of fiscal 2024 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement). Name and Title Date of Adoption Duration of Rule 10b5-1 Trading Arrangement Aggregate Number of Securities to Be Purchased or Sold Richard C. Puccio, Jr. Executive Vice President and Chief Financial Officer September 17, 2024 Until April 30, 2025, or such earlier date upon which all transactions are completed or expire without execution Sale of up to 5,000 shares | |||||
| Gregory Bryant Executive Vice President and President of Business Units |
Adopted 10b5-1 plan | Jun 25, 2024 | up to 203,944 | Jun 30, 2025 | 10-Q Aug 21, 2024 |
What the company wroteThe following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our directors or officers during the third quarter of fiscal 2024 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement). Name and Title Date of Adoption Duration of Rule 10b5-1 Trading Arrangement Aggregate Number of Securities to Be Purchased or Sold Gregory Bryant Executive Vice President and President of Business Units June 25, 2024 Until June 30, 2025, or such earlier date upon which all transactions are completed or expire without execution Sale of up to 203,944 shares (1) (1) Includes 50,000 shares owned outright and 35,187 shares underlying restricted stock units (RSUs). Also includes 118,757 shares underlying performance-based RSUs (PRSUs) as described in the table below. PRSUs may be earned based on the achievement of Company performance targets anywhere from zero to 200% of the target award. Shares Underlying PRSUs Shares Earned to Date Total Shares that May be Earned Total Shares Issued 10,615 -- 21,230 -- 80,046 120,069 -- 69,820* 28,096 22,472 33,708 -- *Represents the total number of shares actually earned and vested, less shares withheld by the Company in satisfaction of withholding taxes, that may be sold. For both RSUs and PRSUs, the Company withholds shares in payment of withholding taxes in connection with the vesting of such awards. | |||||
| Vincent Roche Chief Executive Officer and Chair of the Board of Directors |
Adopted 10b5-1 plan | Mar 1, 2024 | up to 90,017,000 | 426 days | 10-Q May 22, 2024 |
| James Mollica Vice President, Finance and Sales Operations and former Interim Chief Financial Officer |
Adopted 10b5-1 plan | Nov 28, 2023 | up to 4,381,000 | 213 days | 10-Q Feb 21, 2024 |
| Gregory Bryant Executive Vice President and President of Business Units |
Adopted plan | – | not stated | – | 10-Q Feb 19, 2025 |
Show the other 5 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 14 filings checked since May 24, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $4.3M | Stock Option Exercise | adopted Dec 3, 2025 | 10,000 shares from Nov 2, 2026 |
| Oct 20, 2026 | Puccio Richard C Jr Officer |
1,500 | $584K | Restricted Stock Vesting | adopted May 21, 2026 | 1,500 shares from Oct 20, 2026 |
| Oct 8, 2026 | Jain Vivek Officer |
3,306 | $1.3M | Restricted Stock Vesting | none given | 3,305 shares from Oct 8, 2026 |
| Oct 7, 2026 | Jain Vivek Officer |
2,000 | $820K | Restricted Stock Vesting | none given | 5,305 shares from Oct 7, 2026 |
| Oct 6, 2026 | Puccio Richard C Jr Officer |
1,500 | $632K | Restricted Stock Vesting | adopted May 21, 2026 | 3,000 shares from Oct 6, 2026 |
| Oct 2, 2026 | Nakamura Katsufumi Officer |
1,200 | $498K | ESPP Purchase; Restricted Stock Vesting | none given | 1,200 shares from Oct 2, 2026 |
| Oct 2, 2026 | Jain Vivek Officer |
2,000 | $834K | Restricted Stock Vesting | none given | 7,305 shares from Oct 2, 2026 |
| Oct 1, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $4.0M | Stock Option Exercise | adopted Dec 3, 2025 | 10,000 shares from Oct 1, 2026 |
| Sep 22, 2026 | Puccio Richard C Jr Officer |
1,500 | $573K | Restricted Stock Vesting | adopted May 21, 2026 | 4,500 shares from Sep 22, 2026 |
| Sep 9, 2026 | Raymond S. Stata Director |
7,080 | $2.6M | Founder's Shares | adopted Mar 6, 2026 | none found |
| Sep 8, 2026 | Puccio Richard C Jr Officer |
1,500 | $545K | Restricted Stock Vesting | adopted May 21, 2026 | 4,500 shares from Sep 8, 2026 |
| Sep 1, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $3.6M | Stock Option Exercise | adopted Dec 3, 2025 | 20,000 shares from Sep 1, 2026 |
| Aug 27, 2026 | Golz Karen Director |
1,000 | $374K | Restricted Stock Vesting | adopted Mar 12, 2026 | 1,000 shares from Aug 27, 2026 |
| Aug 26, 2026 | Puccio Richard C Jr Officer |
2,683 | $1.0M | Restricted Stock Vesting | adopted May 21, 2026 | 5,683 shares from Aug 26, 2026 |
| Aug 3, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $3.6M | Stock Option Exercise | adopted Dec 3, 2025 | 20,000 shares from Aug 3, 2026 |
| Jul 13, 2026 | Golz Karen Director |
1,000 | $390K | Restricted Stock Vesting | adopted Mar 12, 2026 | 1,000 shares from Jul 13, 2026 |
| Jul 1, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $3.9M | Stock Option Exercise | adopted Dec 3, 2025 | 10,000 shares from Jul 1, 2026 |
| Jun 12, 2026 | Golz Karen Director |
1,000 | $412K | Restricted Stock Vesting | adopted Mar 12, 2026 | 1,000 shares from Jun 12, 2026 |
| Jun 9, 2026 | Raymond S. Stata Director |
9,928 | $4.0M | Founder's Shares | adopted Mar 6, 2026 | none found |
| Jun 2, 2026 | Cotter Martin Officer |
17,594 | $7.4M | Option Granted - 03/08/2017 | none given | 17,594 shares from Jun 2, 2026 |
| Jun 1, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $4.0M | Option Granted - 03/13/2019 | adopted Dec 3, 2025 | 20,000 shares from Jun 1, 2026 |
| May 26, 2026 | ROCHE VINCENT Officer, Director |
30,000 | $12.5M | Option Granted - 12/15/2020 | none given | 40,000 shares from May 26, 2026 |
| May 22, 2026 | ROCHE VINCENT Officer, Director |
30,000 | $11.9M | Option Granted - 12/15/2020 | none given | 70,000 shares from May 22, 2026 |
| May 1, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $4.0M | Options Granted - 03/11/2020 | adopted May 23, 2025 | 70,000 shares from May 1, 2026 |
| Apr 1, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $3.2M | Option Granted - 03/11/2020 | adopted May 23, 2025 | 10,000 shares from May 1, 2026 |
| Mar 3, 2026 | STATA RAY Director |
2,524 | $856K | Option Granted - 03/09/2016 | none given | none found |
| Mar 2, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $3.5M | Option Granted - 03/11/2020 | adopted May 23, 2025 | none found |
| Feb 25, 2026 | Sondel Michael Officer |
4,199 | $1.5M | Restricted Stock Vesting | none given | none found |
| Feb 4, 2026 | Ray Stata Director |
12,500 | $4.0M | Founder's Shares | adopted Jan 9, 2025 | none found |
| Feb 2, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $3.1M | Option Granted 03/11/2020 | adopted May 23, 2025 | none found |
| Jan 9, 2026 | Nakamura Katsufumi Officer |
500 | $151K | Restricted Stock Vesting | none given | none found |
| Jan 7, 2026 | Nakamura Katsufumi Officer |
500 | $145K | ESPP Purchase; Restricted Stock Vesting | none given | none found |
| Jan 5, 2026 | Cotter Martin Officer |
10,000 | $2.8M | ESPP Purchase; Restricted Stock Vesting | none given | none found |
| Jan 2, 2026 | ROCHE VINCENT Officer, Director |
10,000 | $2.8M | Options Granted - 03/11/2020 | adopted May 23, 2025 | none found |
| Dec 17, 2025 | Cotter Martin Officer |
5,000 | $1.4M | Restricted Stock Vesting | none given | none found |
| Dec 12, 2025 | ROCHE VINCENT Officer, Director |
10,000 | $2.8M | Options Granted - 03/11/2020 | adopted May 23, 2025 | none found |
| Dec 10, 2025 | Sondel Michael Officer |
8,169 | $2.3M | Option Granted 03/08/2017; Option Granted 03/13/2019; Option Granted 03/29/2018 | none given | none found |
| Dec 1, 2025 | Jain Vivek Officer |
5,914 | $1.6M | Restricted Stock Vesting | none given | none found |
| Nov 4, 2025 | Raymond S. Stata Director |
18,750 | $4.3M | Acquired as compensation -- Restricted Stock Units; Founder's Shares | adopted Jan 9, 2025 | none found |
| Nov 3, 2025 | ROCHE VINCENT Officer, Director |
10,000 | $2.3M | Option Granted - 03/11/2020 | adopted May 23, 2025 | none found |
Show the other 32 notices
From the Form 144 XML filed with the SEC, since Nov 3, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.